Kidney Cancer
Agency approves new treatment for gastrointestinal and kidney cancer
Published in Medical Letter on the CDC and FDA, March 5th, 2006
This action marks the first time the agency has approved a new oncology product for two indications simultaneously.
Sutent, which received a priority review and was approved in less than 6 months, is a tyrosine kinase inhibitor working through multiple targets to deprive the tumor cells of the blood and nutrients needed to grow.
"Approval is a major step forward in making breakthrough treatments available...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Anthrax Vaccines
Effects of storage on plasmid stability in Bacillus anthracis are reported - Epidemiology
Prevalence of Staphylococcus aureus nasal colonization is high in U.S. - Epidemiology
Report examines prevalence of hepatitis A virus infection in U.S. population - HIV/AIDS Risk Factors
Effectiveness of community outreach to prevent HIV/AIDS in drug users is examined - HIV/AIDS Risk Factors
Report presents results of the Expanded HIV Risk Factor Assessment Project - Addiction Medicine
Depictions of substance use in reality television send mixed messages - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
